"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Penicilline","Piperacillina-Tazobactam",4537,"24.2","23.0","25.5"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Cefalosporine III generazione","Ceftazidime",4473,"19.3","18.2","20.5"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Cefalosporine III generazione","Cefepime",3652,"18.3","17.1","19.6"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Carbapenemi","Imipenem",2861,"19.8","18.4","21.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Carbapenemi","Meropenem",4557,"10.1","9.3","11.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Aminoglicosidi","Amikacina",4327,"4.3","3.7","4.9"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Aminoglicosidi","Gentamicina",2486,"11.9","10.7","13.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Fluorochinoloni","Ciprofloxacina",4591,"18.0","16.9","19.2"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Fluorochinoloni","Levofloxacina",704,"29.4","26.1","32.9"
